Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hirsch

Showing results (401-410 of 686) with videos related to

Pageof 69
Sort By:
Therapeutic Advances in Infectious Disease|June 19, 2023
Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohortKaylyn N Billmeyer, Jennifer K Ross, Elizabeth B Hirsch, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteriaElizabeth B Hirsch, Kimberly R Ledesma, Kai-Tai Chang, et al.
The American Journal of Physiology|May 1, 1991
Catecholamines in prevention of hypoglycemia during exercise in humansJ C Marker, I B Hirsch, L J Smith, et al.
Journal of Diabetes and Its Complications|May 6, 2018
Clinically significant cognitive impairment in older adults with type 1 diabetesNaomi S Chaytor, Celestina Barbosa-Leiker, Christopher M Ryan, et al.
Diabetes Technology & Therapeutics|January 8, 2021
Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin InjectionsSara Hallström, Irl B Hirsch, Magnus Ekelund, et al.
Metabolomics : Official Journal of the Metabolomic Society|November 23, 2018
Volatile metabolic diversity of <i>Klebsiella pneumoniae</i> in nutrient-replete conditionsChristiaan A Rees, Katherine V Nordick, Flavio A Franchina, et al.
JAMA Network Open|October 31, 2025
Continuous Glucose Monitoring Frequency and Glycemic Control in People With Type 2 DiabetesIrl B Hirsch, Satish K Garg, Enrico Repetto, et al.
Diabetes Technology & Therapeutics|March 18, 2025
Evaluating the Adequacy of Coefficient of Variation and Standard Deviation as Metrics of Glucose Variability in Type 1 Diabetes Based on Data from the GOLD and SILVER TrialsPavel Fatulla, Henrik Imberg, Sofia Sterner Isaksson, et al.
Microbiology Spectrum|June 28, 2024
Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for <i>Klebsiella pneumoniae</i>Morgan L Bixby, Ellora C Daley, Lindsey B Collins, et al.
Family Planning Perspectives|July 1, 1988
The Baltimore pregnancy prevention program for urban teenagers. I. How did it work?L S Zabin, M B Hirsch, R Streett, et al.
Pageof 69

Showing results (401-410 of 686) with videos related to

Sort By:
Pageof 69
Therapeutic Advances in Infectious Disease|June 19, 2023
Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohortKaylyn N Billmeyer, Jennifer K Ross, Elizabeth B Hirsch, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteriaElizabeth B Hirsch, Kimberly R Ledesma, Kai-Tai Chang, et al.
The American Journal of Physiology|May 1, 1991
Catecholamines in prevention of hypoglycemia during exercise in humansJ C Marker, I B Hirsch, L J Smith, et al.
Journal of Diabetes and Its Complications|May 6, 2018
Clinically significant cognitive impairment in older adults with type 1 diabetesNaomi S Chaytor, Celestina Barbosa-Leiker, Christopher M Ryan, et al.
Diabetes Technology & Therapeutics|January 8, 2021
Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin InjectionsSara Hallström, Irl B Hirsch, Magnus Ekelund, et al.
Metabolomics : Official Journal of the Metabolomic Society|November 23, 2018
Volatile metabolic diversity of <i>Klebsiella pneumoniae</i> in nutrient-replete conditionsChristiaan A Rees, Katherine V Nordick, Flavio A Franchina, et al.
JAMA Network Open|October 31, 2025
Continuous Glucose Monitoring Frequency and Glycemic Control in People With Type 2 DiabetesIrl B Hirsch, Satish K Garg, Enrico Repetto, et al.
Diabetes Technology & Therapeutics|March 18, 2025
Evaluating the Adequacy of Coefficient of Variation and Standard Deviation as Metrics of Glucose Variability in Type 1 Diabetes Based on Data from the GOLD and SILVER TrialsPavel Fatulla, Henrik Imberg, Sofia Sterner Isaksson, et al.
Microbiology Spectrum|June 28, 2024
Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for <i>Klebsiella pneumoniae</i>Morgan L Bixby, Ellora C Daley, Lindsey B Collins, et al.
Family Planning Perspectives|July 1, 1988
The Baltimore pregnancy prevention program for urban teenagers. I. How did it work?L S Zabin, M B Hirsch, R Streett, et al.
Pageof 69